Late effects of chronic graft-vs.-host disease in minor salivary glands

Journal of Oral Pathology and Medicine

Volumn 34, Issue 8, 2005, Pages 486-493

  Alborghetti, M R ^a   Correa M E P ^b   Adam, R L ^a   Metze, K ^a   Coracin, F L ^b   De Souza, C A ^b   Cintra, Maria Letícia ^a,b  

^a Hematology and Hemotherapy Center   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Bone marrow transplantation; Grades; GVHD; Minor salivary gland; Pathology; Xerostomia

Indexed keywords

ACINAR CELL; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LYMPHOCYTIC INFILTRATION; MALE; MINOR SALIVA GLAND; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; SALIVARY GLAND BIOPSY; SCHOOL CHILD; TREATMENT OUTCOME; XEROSTOMIA;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; BIOPSY; BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; CHRONIC DISEASE; CYCLOSPORINE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; PERIODIC ACID-SCHIFF REACTION; PREDNISONE; SALIVARY GLANDS, MINOR; XEROSTOMIA;

EID: 23844436651     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2005.00347.x     Document Type: Article

References (33)

1. Sullivan KM, Shulman HM, Storb R, Weiden PL. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267-76.
2. Gratwhol AA, Moutsopoulos HM, Chused TM, et al. Sjögren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med 1977; 87: 703-6.
3. Nagler R, Marmary Y, Krausz Y, Chisin R, Markitziu A, Nagler A. Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1996; 17: 219-24.
4. Nagler RM, Laufer D, Nagler A. Parotid gland dysfunction in an animal model of chronic graft-versus-host disease. Arch Otolaryngol Head Neck Surg 1996; 122: 1057-60.
5. Izutsu KT, Sullivan KM, Schubert MM, et al. Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease. Transplantation 1983; 35: 441-46.
6. Izutsu KT, Schubert MM, Truelove El E, et al. The predictive value of elevated labial saliva sodium concentration: its relation to labial gland pathology in bone marrow transplant recipients. Hum Pathol 1983; 14: 29-35.
7. Schubert MM, Sullivan KM, Morton TH, et al. Oral manifestations of chronic graft-v-host disease. Arch Intern Med 1984; 144: 1591-5.
8. Sale GE, Shulman HM, Schubert MM, et al. Oral and ophthalmic pathology of graft versus host disease in man: predictive value of the lip biopsy. Hum Pathol 1981; 12: 1022-30.
9. Hiroki A, Nakamura S, Shinohara M, Oka M. Significance of oral examination in chronic graft-versus-host-disease. J Oral Pathol Med 1994; 23: 209-15.
10. Schmitz N, Beksac M, Hasenclever D, et al. European Group for Blood and Marrow Transplantation. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard risk for leukaemia. Blood 2002; 100: 761-67.
11. Sullivan KM, Siadak MF, Witherspoon RP. Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation. Transplant Proc 1990; 22: 1336-8.
12. Horn TD, Rest EB, Mirenski Y, Corio RL, Zahurak ML, Vogelsang GB. The significance of oral mucosal and salivary gland pathology after allogeneic bone marrow transplantation. Arch Dermatol 1995; 131: 964-5.
13. Metze K, Adam RL. Quantification in histopathology - some pitfalls. Braz J Med Biol Res 2005; 38: 141-3.
14. Kurtin PJ, Pinkus GS. Leukocyte common antigen - a diagnostic discriminant between hematopoietic and non-hematopoietic neoplasms in paraffin sections using monoclonal antibodies: correlation with immunologic studies and ultrastructural localization. Hum Pathol 1985; 16: 353-65.
15. Schubert MM, Sullivan KM. Recognition, incidence and management of oral graft-versus-host disease. NCI Monogr 1990; 9: 135-43.
16. Nagler RM, Nagler A. Major salivary gland involvement in graft-versus-host disease: considerations related to pathogenesis, the role of cytokines and therapy. Cytokines Cell Mol Ther 1999; 5: 227-32.
17. Nagler RM, Nagler A. Sialometrical and sialochemical analysis of patients with chronic graft-versus-host disease-a prolonged study. Cancer Invest 2003; 21: 34-40.
18. Fox PC, van der Ven PF, Sonies BC, Weiffenbach JM, Baum BJ. Xerostomia: evaluation of a symptom with increasing significance. J Am Dent Assoc 1985; 110: 519-25.
19. Peterson DE. Xerostomia - any progress? Support Care Cancer 2003; 11: 199-200.
20. Nagler R, Marmary Y, Krausz YA. Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1996; 17: 219-24.
21. Nakamura S, Hiroki A, Shinohara M, et al. Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 556-63.
22. Loughran TP Jr, Sullivan K, Morion T, et al. Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Blood 1990; 76: 228-34.
23. Levy S, Nagler A, Okon S, Marmary Y. Parotid salivary gland dysfunction in chronic graft-versus-host disease (cGVHD): a longitudinal study in a mouse model. Bone Marrow Transplant 2000; 25: 1073-8.
24. Shubert MM, Izutsu KT. Iatrogenic causes of salivary gland dysfunction. J Dent Res 1987; 66 (Spec no): 680-8.
25. Blomgren J, Jansson S, Rödjer S, Birkhed D. Secretion rate from minor salivary glands in patients with malignant hematological diseases receiving chemotherapy a pilot study. Swed Dent J 2002; 26: 75-80.
26. Lockhart PB, Sonis ST. Alterations in the oral mucosa caused by chemotherapeutic agents. A histologie study. J Dermatol Surg Oncol 1981; 12: 1019-25.
27. Scully C. Drug effects on salivary glands: dry mouth. Oral Dis 2003; 9: 165-76.
28. Ilan Y, Gotsman I, Pines M, et al. Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic versus host disease in a murine model. Blood 2000; 95: 3613-9.
29. Nagler RM, Nagler A. The molecular basis of salivary gland involvement in Graft-vs.-Host Disease. J Dent Res 2004; 83: 98-103.
30. Cooke KR, Ferrara JL. A protective gene for graft-versus-host disease. N Engl J Med 2003; 349: 2183-4.
31. Hiroki A, Nakamura S, Shinohara M, et al. A comparison of glandular involvement between chronic graft-versus-host disease and Sjögren's syndrome. Int J Oral Maxillofac Surg 1996; 25: 298-307.
32. Chaushu S, Chaushu G, Garfunkel A, Slavin S, Or R, Yefenof E. Salivary immunoglobulins in recipients of bone marrow grafts. II. A longitudinal follow-up. Bone Marrow Transplant 1994; 14: 871-6.
33. Takahashi S, Schoch E, Walker NI. Origin of acinar cell regeneration after atrophy of the rat parotid induced by duct obstruction. Int J Exp Pathol 1998; 79: 293-301.